Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking human LAIR-collagen interaction

MLA

Ana Paucarmayta, et al. “Cancer Immunotherapy by NC410, a LAIR-2 Fc Protein Blocking Human LAIR-Collagen Interaction.” ELife, vol. 10, Sept. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....28861c029e989fddbc172a2b376953c1&authtype=sso&custid=ns315887.

APA

Ana Paucarmayta, Emma J de Ruiter, Dallas Flies, Nicholas Willumsen, Akashdip Singh, Linjie Tian, Linda Liu, Saskia V. Vijver, Morten A. Karsdal, M. Inês Pascoal Ramos, Linde Meyaard, Chang Song, Stefan M. Willems, Sol Langermann, Jason Bosiacki, Jahangheer Shaik, Eline Elshof, Christina Jensen, & Zachary Cusumano. (2020). Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking human LAIR-collagen interaction. ELife, 10.

Chicago

Ana Paucarmayta, Emma J de Ruiter, Dallas Flies, Nicholas Willumsen, Akashdip Singh, Linjie Tian, Linda Liu, et al. 2020. “Cancer Immunotherapy by NC410, a LAIR-2 Fc Protein Blocking Human LAIR-Collagen Interaction.” ELife 10 (September). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....28861c029e989fddbc172a2b376953c1&authtype=sso&custid=ns315887.